<![CDATA[NOVO — Marts 2022]]>Novo/Citi: Anbefalingen løftes til "køb" fra "neutral" https://proinvestor.com/investornyt/789544/novo-citi-anbefalingen-loftes-til-kob-fra-neutral

]]>https://dev.proinvestor.com/forum/topic/400283/novo-marts-2022RSS for NodeSat, 06 Jun 2026 18:59:11 GMTWed, 02 Mar 2022 04:56:16 GMT60<![CDATA[Reply to NOVO — Marts 2022 on Tue, 29 Mar 2022 05:42:55 GMT]]>ikke megen kredit på kursen

]]>https://dev.proinvestor.com/forum/post/7978095https://dev.proinvestor.com/forum/post/7978095Tue, 29 Mar 2022 05:42:55 GMT<![CDATA[Reply to NOVO — Marts 2022 on Tue, 29 Mar 2022 02:55:32 GMT]]>Novo: Ozempic-dosis på 2,0 mg godkendt i USA - GENT https://proinvestor.com/investornyt/801571/novo-ozempic-dosis-pa-20-mg-godkendt-i-usa-gent

]]>https://dev.proinvestor.com/forum/post/7978094https://dev.proinvestor.com/forum/post/7978094Tue, 29 Mar 2022 02:55:32 GMT<![CDATA[Reply to NOVO — Marts 2022 on Mon, 28 Mar 2022 05:31:05 GMT]]>****NOVO/DNB: KURSMÅL HÆVES TIL 850 KR. FRA 780 KR.

]]>https://dev.proinvestor.com/forum/post/7978093https://dev.proinvestor.com/forum/post/7978093Mon, 28 Mar 2022 05:31:05 GMT<![CDATA[Reply to NOVO — Marts 2022 on Fri, 25 Mar 2022 07:02:49 GMT]]>Novo-bestyrelsesformand tror på globalisering trods spændinger https://proinvestor.com/investornyt/800261/novo-bestyrelsesformand-tror-pa-globalisering-trods-spaendinger

]]>https://dev.proinvestor.com/forum/post/7978091https://dev.proinvestor.com/forum/post/7978091Fri, 25 Mar 2022 07:02:49 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 24 Mar 2022 13:17:45 GMT]]>Novo/CEO: Har sikret medicin i to måneder til patienter i Ukraine https://proinvestor.com/investornyt/799863/novo-ceo-har-sikret-medicin-i-to-maneder-til-patienter-i-ukraine

]]>https://dev.proinvestor.com/forum/post/7978090https://dev.proinvestor.com/forum/post/7978090Thu, 24 Mar 2022 13:17:45 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 24 Mar 2022 10:50:50 GMT]]>Video - TA på Novo Nordisk

]]>https://dev.proinvestor.com/forum/post/7978089https://dev.proinvestor.com/forum/post/7978089Thu, 24 Mar 2022 10:50:50 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 24 Mar 2022 07:51:40 GMT]]>Novo: Marked for fedmemedicin i USA kan blive 500 mia. kr. værd i 2030 https://proinvestor.com/investornyt/799668/novo-marked-for-fedmemedicin-i-usa-kan-blive-500-mia-kr-vaerd-i-2030

]]>https://dev.proinvestor.com/forum/post/7978086https://dev.proinvestor.com/forum/post/7978086Thu, 24 Mar 2022 07:51:40 GMT<![CDATA[Reply to NOVO — Marts 2022 on Wed, 23 Mar 2022 14:19:46 GMT]]>Test

]]>https://dev.proinvestor.com/forum/post/7978087https://dev.proinvestor.com/forum/post/7978087Wed, 23 Mar 2022 14:19:46 GMT<![CDATA[Reply to NOVO — Marts 2022 on Wed, 16 Mar 2022 06:39:07 GMT]]>Novo/Deutsche: Løfter til "køb" - NY https://proinvestor.com/investornyt/795942/novo-deutsche-lofter-til-kob-ny

]]>https://dev.proinvestor.com/forum/post/7978084https://dev.proinvestor.com/forum/post/7978084Wed, 16 Mar 2022 06:39:07 GMT<![CDATA[Reply to NOVO — Marts 2022 on Mon, 14 Mar 2022 14:16:16 GMT]]>Novo: Blackrocks ejerandel nu under 5 pct. https://proinvestor.com/investornyt/795029/novo-blackrocks-ejerandel-nu-under-5-pct

]]>https://dev.proinvestor.com/forum/post/7978083https://dev.proinvestor.com/forum/post/7978083Mon, 14 Mar 2022 14:16:16 GMT<![CDATA[Reply to NOVO — Marts 2022 on Tue, 08 Mar 2022 04:52:29 GMT]]>Novo anlægger patentsag i USA - vil forhindre kopier af Ozempic - GENT https://proinvestor.com/investornyt/792076/novo-anlaegger-patentsag-i-usa-vil-forhindre-kopier-af-ozempic-gent

]]>https://dev.proinvestor.com/forum/post/7978088https://dev.proinvestor.com/forum/post/7978088Tue, 08 Mar 2022 04:52:29 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 03 Mar 2022 11:39:08 GMT]]>Novo/dir: Mere end fordobler mål for fedme til over 25 mia kr i 25-NY2 https://proinvestor.com/investornyt/790196/novo-dir-mere-end-fordobler-mal-for-fedme-til-over-25-mia-kr-i-25-ny2

]]>https://dev.proinvestor.com/forum/post/7978079https://dev.proinvestor.com/forum/post/7978079Thu, 03 Mar 2022 11:39:08 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 03 Mar 2022 11:37:46 GMT]]>Novo: Fase 3-data fra ugentligt insulin på vej om et par måneder https://proinvestor.com/investornyt/790225/novo-fase-3-data-fra-ugentligt-insulin-pa-vej-om-et-par-maneder

]]>https://dev.proinvestor.com/forum/post/7978076https://dev.proinvestor.com/forum/post/7978076Thu, 03 Mar 2022 11:37:46 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 03 Mar 2022 11:02:56 GMT]]>det virker da fuldstændig vildt...en dobling eller var det ventet?

]]>https://dev.proinvestor.com/forum/post/7978082https://dev.proinvestor.com/forum/post/7978082Thu, 03 Mar 2022 11:02:56 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 03 Mar 2022 10:51:07 GMT]]>Novo/dir: Mere end fordobler mål for fedme til over 25 mia kr i 25 -NY https://proinvestor.com/investornyt/790183/novo-dir-mere-end-fordobler-mal-for-fedme-til-over-25-mia-kr-i-25-ny

]]>https://dev.proinvestor.com/forum/post/7978085https://dev.proinvestor.com/forum/post/7978085Thu, 03 Mar 2022 10:51:07 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 03 Mar 2022 10:27:12 GMT]]>Novo/dir: Mere end fordobler mål for fedme til over 25 mia kr i 25 -NY
12:23
Novo Nordisk mere end fordobler sin målsætning for salget af vægttabsprodukter til over 25 mia. kr. i 2025.

Det siger koncerndirektør med ansvar for Novos strategi, Camilla Sylvest, torsdag på selskabets kapitalmarkedsdag.

Opjusteringen har været ventet, da Novo nærmest allerede har nået sin gamle målsætning, der blev udstukket i november 2019.

Den tidlige ambition var en fordobling af forretningsområdets salg i 2019

]]>https://dev.proinvestor.com/forum/post/7978081https://dev.proinvestor.com/forum/post/7978081Thu, 03 Mar 2022 10:27:12 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 03 Mar 2022 08:39:35 GMT]]>Novo/dir: Går efter tre nye lægemiddelkandidater årligt fra Dicerna https://proinvestor.com/investornyt/790126/novo-dir-gar-efter-tre-nye-laegemiddelkandidater-arligt-fra-dicerna

]]>https://dev.proinvestor.com/forum/post/7978077https://dev.proinvestor.com/forum/post/7978077Thu, 03 Mar 2022 08:39:35 GMT<![CDATA[Reply to NOVO — Marts 2022 on Thu, 03 Mar 2022 08:01:09 GMT]]>Novo/CEO: Vi er opmuntrede over vækstmomentum https://proinvestor.com/investornyt/790122/novo-ceo-vi-er-opmuntrede-over-vaekstmomentum

]]>https://dev.proinvestor.com/forum/post/7978092https://dev.proinvestor.com/forum/post/7978092Thu, 03 Mar 2022 08:01:09 GMT<![CDATA[Reply to NOVO — Marts 2022 on Wed, 02 Mar 2022 07:19:43 GMT]]>Novo/Sydbank: Bidens forslag om prisloft skaber næppe kursuro https://proinvestor.com/investornyt/789571/novo-sydbank-bidens-forslag-om-prisloft-skaber-naeppe-kursuro

]]>https://dev.proinvestor.com/forum/post/7978078https://dev.proinvestor.com/forum/post/7978078Wed, 02 Mar 2022 07:19:43 GMT<![CDATA[Reply to NOVO — Marts 2022 on Wed, 02 Mar 2022 06:38:58 GMT]]>Novo: Biden vil sænke prisen på receptpligtig medicin i USA - NY https://proinvestor.com/investornyt/789562/novo-biden-vil-saenke-prisen-pa-receptpligtig-medicin-i-usa-ny

]]>https://dev.proinvestor.com/forum/post/7978080https://dev.proinvestor.com/forum/post/7978080Wed, 02 Mar 2022 06:38:58 GMT